Skip to main content
. 2022 Jan 18;204(1):e00486-21. doi: 10.1128/JB.00486-21

TABLE 2.

Oligonucleotides used in this study

Oligonucleotide sequence (5′–3′) Target
Cloning
GGGGGATCCGGGGAGATCGATGCTTATACAGCG sigB, rsbX a fwd (BamHI restriction site underlined)
GGGGTCGACTTTATCAGGTTGAGATACTTTTGGC sigB, rsbX b rev (SalI restriction site underlined)
GGGGTCGACTAACCATAACACCTTTTAAACTAGCG sigB, rsbX c fwd (SalI restriction site underlined)
GGGCCATGGCGTAACCACAAGTCCAATAAGTGG sigB, rsbX d rev (NcoI restriction site underlined)
AGTCCCAATATAATCATTTATCAACTC pMAD_seq F
TGGTCGTCATCTACCTG pMAD_seq R
GGGGGATCCTGAGGAAGTGGAGTAAATG Comp rsbX fwd (BamHI restriction site underlined)
GGGCTGCAGTGTTCTCACACCCAATCTG Comp rsbX rev (PstI restriction site underlined)
Northern blotting
CAATGAGATCAGCAT lmo2230 L
GCATATTCGAAGTGC lmo2230 U
CCTCCACATTAATGTTTGG lmo0596 fwd
GCAAGAAACCTAGTAAGATGG lmo0596 rev
CGCAACTCTCCTTCTCGATGG lmo1699 fwd
GCTTTATAGCTCGCACTTTGG lmo1699 rev
CCTCGTTATCAACGTCAAAGCC tmRNA fwd
CGGCACTTAAATATCTACGAGC tmRNA rev
RT-qPCR
CATATTCGAAGTGCCATTGC lmo2230_F
CTGAACTAGGTGAATAAGACAAAC lmo2230_R
GGGTACTAGCTGACGGAATTTTATC lmo0596_F
CCCACATACCGAAAAGTAATACGAG lmo0596_R